NewsSOS

Scribe shares surge in public market debut with Eli Lilly and Sanofi as backers

7/24/2026

Shares of Scribe surged during the company's public market debut, the release shows. Scribe is backed by Eli Lilly (LLY) and Sanofi.

Pharmaceutical investors at the listing Scribe's investor base includes Eli Lilly, which trades under the ticker LLY, and Sanofi. Both companies held positions in Scribe when it entered public markets.

The source does not disclose the opening price, trading range, or percentage gain recorded on the debut session.

Opening-day performance Scribe's share price climbed on its first day of public trading, according to the source.